미국의 바이오디펜스 관련 병원체 신속 식별 및 치료 시장

The U.S. market for biodefense-related rapid pathogen identification and treatments is expected to grow from $8.4 billion in 2026 and is projected to reach $12.1 billion by the end of 2031, at a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2026 to 2031.

Report Scope

This report examines the current and future market potential of the U.S. market for biodefense-related rapid pathogen identification and treatments. It offers a detailed analysis of the competitive environment, regulatory scenario, technological development, drivers and restraints, and identifies opportunities and trends in market growth.

The report provides an overview of the U.S. market for biodefense-related rapid pathogen identification and treatments and analyzes market trends. It includes global revenue ($ million) for the base year 2025 and estimated data for the forecast period 2026 to 2031. Based on type, the market is segmented into detection devices, sensors, and therapeutics. The detection devices segment is further segmented based on testing method and device type. The report also focuses on segmentation based on application and end user. The application segmentation includes detection and diagnosis, prevention, and treatment.

By end user, the market is segmented into academic and research institutes, government and defense agencies, hospitals, and pharma and biotechnology companies. The report focuses on the major emerging technologies that affect the market and vendor landscape. It also has a dedicated section of company profiles that covers details of leading key companies.

Report Includes

• 28 data tables and 51 additional tables
• An overview and analysis of the U.S. market for biodefense-related rapid pathogen identification and treatments
• Analyses of market trends, with revenue data for 2023-2025, estimates for 2026, and forecasts through 2031
• Market segmentation analysis by type, including detection devices and sensors
• Market breakdown by application, including detection and diagnosis, prevention, and treatment
• Market analysis by end user, including academic and research institutes, government and defense agencies, hospitals, and pharma and biotechnology companies
• Facts and figures related to market dynamics, including key drivers, restraints, and opportunities
• Insights derived from Porter's Five Forces analysis
• Discussion of emerging technologies, recent developments, and patent activity
• Analysis of the competitive landscape, including industry structure and company share analysis
• Company profiles of the leading players, including Thermo Fisher Scientific Inc., Biomerieux, F. Hoffmann-La Roche Ltd., Abbott, and OraSure Technologies Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Conclusion

Chapter 2 Market Overview

• Overview
• Delivery and Detection
• Methods of Dissemination
• Rapid Identification Products
• Treatment
• Vaccines
• Antibiotics
• Antimicrobial Resistance
• Porter's Five Forces Analysis
• Threat of New Entrants (Moderate)
• Bargaining Power of Suppliers (Low to Moderate)
• Bargaining Power of Buyers (High)
• Threat of Substitute Products (Low)
• Industry Rivalry (High)
• Macroeconomic Factor Analysis
• U.S. Tariffs
• Increasing Healthcare Expenditures
• Geopolitical Factors

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• High Federal Funding and Biodefense Investments
• Increasing Need for Infectious Disease Detection and Outbreak Surveillance
• Increased Emergency Use Authorizations and Product Approvals
• Market Restraints
• High Equipment and Testing Costs
• Lack of Awareness and Underdiagnosis of Infectious Conditions
• Regulatory Barriers
• Market Opportunities
• Pathogen-Agnostic Detection Approaches
• Point-of-Care Testing
• Self-Testing Kits for Pathogen Detection

Chapter 4 Regulatory Landscape

• U.S. Regulatory Aspects of Pathogen Identification Devices
• U.S. Regulatory Aspects of Therapeutics for Pathogenic Conditions

Chapter 5 Emerging Technologies

• Key Takeaways
• Emerging Technologies
• Multiplex PCR Syndromic Testing
• AI-Based Biodefense Surveillance
• Messenger RNA (mRNA) Vaccines
• CRISPR-Based Diagnostics
• Lab-on-a-Chip Systems for Public Health Monitoring

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis by Type
• Key Takeaways
• Detection Devices
• Sensors
• Therapeutics
• Market Analysis by Application
• Key Takeaways
• Detection and Diagnosis
• Prevention
• Treatment
• Market Analysis by End User
• Key Takeaways
• Government and Defense Agencies
• Hospitals
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutions

Chapter 7 Competitive Intelligence

• Key Takeaways
• Industry Structure
• Competitive Analysis of U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments
• Strategic Analysis

Chapter 8 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• ABBOTT
• AGILENT TECHNOLOGIES INC.
• BD
• BIOMERIEUX
• BIO-RAD LABORATORIES INC.
• CEPHEID
• CHARLES RIVER LABORATORIES
• F. HOFFMANN-LA ROCHE LTD.
• GENSCRIPT
• GSK PLC
• ILLUMINA INC.
• JOHNSON & JOHNSON
• ORASURE TECHNOLOGIES INC.
• QIAGEN
• REVVITY
• THERMO FISHER SCIENTIFIC INC.
• Emerging Startups/Market Disruptors